Rubicyt 10mg Injection
Marketer
Cytogen Pharmaceuticals India Pvt Ltd
Salt Composition
Epirubicin (10mg)
Overview Rubicyt 10mg Injection
Oncaspar 10mg injection treats various hematological malignancies, as well as cancers affecting the breast, stomach, lung, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously via infusion by a healthcare professional, it's utilized either alone or in conjunction with other medications as part of combined chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may fluctuate. Strictly adhere to your doctor's prescribed regimen; improper use or overdose may lead to severe adverse effects. Therapeutic benefits may not be immediately apparent; continue treatment unless directed otherwise. Note that it diminishes the efficacy of oral contraceptives, necessitating reliable contraception for both partners throughout treatment. Common side effects comprise nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests to monitor blood cell counts, renal, hepatic, and cardiac function are mandatory. Prior to commencing treatment, disclose any liver or heart conditions, and provide a comprehensive list of all current medications, as interactions may compromise efficacy or alter the drug's action. Inform your doctor if you are pregnant or lactating.
Uses of Rubicyt 10mg Injection
Malignancy
Major Benefits of Rubicyt 10mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Rubicyt 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Rubicyt 10mg Injection:
Administering this medication will be done by your physician or their assigned nurse; self-medication is strictly prohibited.
How Rubicyt 10mg Injection works:
Cytarabine 10mg Injection is a chemotherapeutic agent used in breast cancer treatment. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within breast cancer cells. Concurrently, it generates reactive oxygen species, inducing DNA damage. This dual action arrests and ultimately eliminates malignant breast cells.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Rubicyt 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Rubicyt 10mg Injection during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Rubicyt 10mg Injection is contraindicated during lactation. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administration of Rubicyt 10mg Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Rubicyt 10mg Injection, can temporarily diminish driving proficiency.
KidneySAFE IF PRESCRIBED
The use of Rubicyt 10mg Injection in individuals with impaired kidney function is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended. Patients exhibiting serum creatinine exceeding 5 mg/dL might benefit from a reduced dosage.
LiverCAUTION
Patients with liver impairment should receive Rubicyt 10mg Injection cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Rubicyt 10mg Injection; physician consultation is advised.
What if you forget to take Rubicyt 10mg Injection :
NA
Facts to Know About Rubicyt 10mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently